Biotechnology News

October 10, 2012

NAARDEN, The Netherlands--(BUSINESS WIRE)--BAC BV, the leading provider of antibody-based affinity purification technology, announced today that a successful long-term collaboration with GE Healthcare, the healthcare business of GE (NYSE: GE), to...

October 10, 2012

NEW YORK--(BUSINESS WIRE)--In 2050, the number of people aged 60 years and older worldwide will increase from 605 million to nearly 2 billion.2 While it’s good news that people are living longer, the number of older adults who will be affected by...

October 10, 2012

ARDSLEY, N.Y.--(BUSINESS WIRE)--Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced safety data from more than 62,400 people with multiple sclerosis (MS) taking AMPYRA (dalfampridine) Extended Release Tablets, 10 mg during the first two...

October 10, 2012

NEW PROVIDENCE, N.J.--(BUSINESS WIRE)--Svelte® Medical Systems today announced the appointment of Jack Darby to the position of President and Chief Executive Officer. Mark Pomeranz will continue to play a key leadership role at Svelte, serving as...

October 10, 2012

VIENNA--(BUSINESS WIRE)--CLC bio releases white paper on their new read mapping algorithm and with four human datasets benchmarks for performance and accuracy against the open source read mappers BWA, Bowtie2 and SMALT.

October 10, 2012

TEL AVIV, Israel--(BUSINESS WIRE)--The 10th Go4Europe Conference will be held on October 29th at the Hilton Tel Aviv. Organized by Cukierman Investment House Ltd. and Catalyst Fund, Go4Europe is one of the most prestigious business conferences in...

October 10, 2012

NOKOMIS, Fla.--(BUSINESS WIRE)--RBCC Increases Focus on Parkinson’s Disease

October 10, 2012

BARCELONA, Spain & SINGAPORE--(BUSINESS WIRE)--Almirall (ALM:MC) and Invida Holdings Private Limited, a member of the Menarini Group, are pleased to announce that Almirall has granted Invida commercial rights for Aclidinium in Australia and...

October 10, 2012

SAN DIEGO--(BUSINESS WIRE)--Medistem's Endometrial Regenerative Cells (ERC) were compared by microarray analysis with bone stem cells (MSC) by the NIH. Increase expression of genes associated with angiogenesis was published.

October 10, 2012

WESTON, Mass.--(BUSINESS WIRE)--Biogen Idec (NASDAQ: BIIB) will have extensive data from the company’s leading multiple sclerosis (MS) franchise presented during the 28th Congress of the European Committee for Treatment and Research in Multiple...

October 10, 2012

JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) today announced data from the Phase III Glatiramer Acetate Low-Frequency Administration (GALA) study. The GALA study was designed to evaluate the efficacy, safety and...

October 10, 2012

BEERSE, Belgium--(BUSINESS WIRE)--A newly-refreshed version of the Schizophrenia24x7 website, visited by more than 260,000 people from 190 different countries since its launch in 2011, has gone live today – World Mental Health Day – a day devoted...

October 9, 2012

ALACHUA, Fla.--(BUSINESS WIRE)--On October 5, 2012 PDL provided AxoGen with an aggregate of $20.8 million.

October 9, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) today announced it will host its third quarter 2012 investor update conference call and webcast at 8:30 a.m. Eastern Time on Tuesday, October 16, 2012. Individuals...

October 9, 2012

PARSIPPANY, N.J.--(BUSINESS WIRE)--DESIR-ABLE study finds desirudin (Revasc®, Iprivask®), a blood thinner used to prevent dangerous blood clots, has a favorable safety profile in high risk surgical and medical patients.

October 9, 2012

WASHINGTON--(BUSINESS WIRE)--BIO submitted comments to EPA opposing recent requests for a waiver of the Renewable Fuel Standard. The waiver would not benefit those seeking it, but would harm advanced biofuel producers.

October 9, 2012

ATLANTA--(BUSINESS WIRE)--Vindon Scientific smart controller, stability storage digital control, stability storage services and equipment, see it at AAPS Chicago

October 9, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Entry-level medical science liaisons (MSLs) earn an average $97,000, according to a new benchmarking study published by Cutting Edge Information.

October 9, 2012

CARY, N.C.--(BUSINESS WIRE)--ISR's report provides a never before seen analysis of how social media is changing the Hep C market, how patients are searching for Hep C content online. The report also includes a market analysis.

October 9, 2012

ROCKVILLE, Md.--(BUSINESS WIRE)--EMERGENT BIOSOLUTIONS TO RELEASE THIRD QUARTER 2012 FINANCIAL RESULTS AND CONDUCT A CONFERENCE CALL AT 8:00 AM EASTERN ON NOVEMBER 1, 2012.

October 9, 2012

MINNEAPOLIS--(BUSINESS WIRE)--LifeScience Alley announces 10 New Technology Showcase companies to be on display at their 2012 Conference in Minneapolis on December 5, 2012.

October 9, 2012

EVRY, France--(BUSINESS WIRE)--Regulatory News: Global Bioenergies (Paris:ALGBE) demonstrates a novel metabolic pathway enabling the direct conversion of renewable resources to propylene, one of the main building blocks of the petrochemical...

October 9, 2012

ATLANTA--(BUSINESS WIRE)--Berry Technology Solutions and Attain LLC were awarded a $14.3 million contract by the Centers for Disease Control and Prevention to support its VTrckS vaccine tracking system.

October 9, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--US managed markets teams benefit greatly by having clear communication lines with pharmaceutical marketing and clinical development teams, according to a recent study by Cutting Edge Information.

October 9, 2012

BOSTON--(BUSINESS WIRE)--Acetylon will participate on a financing panel and provide a corporate update at BIO Investor Forum today, October 9, 2012, in San Francisco, CA.

October 9, 2012

ANN ARBOR, Mich.--(BUSINESS WIRE)--AlphaCore Pharma, announced today that results from the company’s Phase 1 clinical trial have met the primary endpoint by demonstrating the safety and tolerability of the drug ACP-501 (recombinant human LCAT)....

October 9, 2012

BONN, Germany--(BUSINESS WIRE)--Cardionovum GmbH announced today that it has established its distribution network in 57 countries since the beginning of 2012. The Company is commercializing its CE-marked Paclitaxel-coated drug-coated balloon (DCB...

October 9, 2012

NEW YORK--(BUSINESS WIRE)--Members of the Global Virus Network (GVN) release a statement on the new Coronavirus cases that have caused severe disease in one patient and death in another.

October 9, 2012

SAN FRANCISCO--(BUSINESS WIRE)--ClinStar VP Operations Richard Koenig to Present on Value of Including Russia and Ukraine in Your Initial Global Clinical Study Plans and at a Minimum in Your Risk Management and Rescue Study Plans

October 9, 2012

CHESHIRE, Conn.--(BUSINESS WIRE)--Data from Investigator-Initiated Phase 2 Study of Eculizumab (Soliris ®) in Patients with Severe Relapsing Neuromyelitis Optica (NMO)

October 9, 2012

BURLINGTON, Mass.--(BUSINESS WIRE)--Decision Resources, one of the world’s leading research and advisory firms for pharmaceutical and healthcare issues, finds that the drug market for chronic obstructive pulmonary disease (COPD) therapies will...

October 9, 2012

EXTON, Pa.--(BUSINESS WIRE)--BioTrends Research Group, one of the world’s leading research and advisory firms for specialized biopharmaceutical issues, finds that significantly more moderate-to-severe and severe fulminant Crohn’s disease (CD)...

October 9, 2012

SAN FRANCISCO--(BUSINESS WIRE)--PRC Clinical awarded large global clinical trial in orphan-status clinical trial.

October 9, 2012

ANN ARBOR, Mich.--(BUSINESS WIRE)--NanoBio Promotes David Peralta to Chief Executive Officer

October 9, 2012

LINCOLN, Neb.--(BUSINESS WIRE)--LI-COR presents landfill methane emission data at Global Waste Management Symposium. The data was collected using the Eddy Covariance method, the most widely used method for continuous monitoring.

October 9, 2012

BOTHELL, Wash.--(BUSINESS WIRE)--Seattle Genetics, Inc. (NASDAQ:SGEN) announced today that it will receive undisclosed milestone payments under its antibody-drug conjugate (ADC) collaboration with Genentech, a member of the Roche Group (SWX:RO) (...

October 9, 2012

NEWTOWN, Pa.--(BUSINESS WIRE)--Marketing Strategy and Research Expert to Discuss How Pharmaceutical Companies Can Achieve Launch Success in New Markets

October 9, 2012

DUBLIN, Ohio--(BUSINESS WIRE)--Results of Lymphoseek® Phase 3 Clinical Trials in Melanoma Published in Annals of Surgical Oncology

October 9, 2012

ASHLAND, Ohio--(BUSINESS WIRE)--A WIL Research bioanalytical chemist, Dr. Hui Tao, will discuss how the Thermo Scientific Q-Exactive Quadruple Orbitrap High Resolution Mass Analyzer can accelerate discovery pharmacokinetic (PK) screening time by...

October 9, 2012

MALVERN, Pa.--(BUSINESS WIRE)--TetraLogic Pharmaceuticals today announced that the U.S. Patent and Trademark Office issued a third patent with claims that cover birinapant, a Smac mimetic currently in Phase 2 clinical studies for the treatment of...

October 9, 2012

ROCKFORD, Ill.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, today introduced the free Thermo Scientific Gene News mobile App for iPhone and Android devices, giving researchers unmatched access to important...

October 9, 2012

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Advanced Cell Technology, Inc. (“ACT”; OTCBB: ACTC), a leader in the field of regenerative medicine, announced today that the Data and Safety Monitoring Board (DSMB), an independent group of medical experts...

October 9, 2012

SAN DIEGO--(BUSINESS WIRE)--Senomyx (NASDAQ:SNMX) EU regulatory approvals open new international markets to Senomyx Savory Flavors and to S2383 Flavor Ingredient, which restores the taste profile in reduced-sucralose products.

October 9, 2012

CHICAGO--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX) will host its 2012 Investor Conference today in Chicago, and during the conference, the company plans to provide its five-year long-range financial outlook, update investors on its...

October 9, 2012

HATFIELD, England--(BUSINESS WIRE)--RSA, the leading global Life Sciences Executive Search and Interim Management specialist, is pleased to announce that Dr François Martin has been appointed Managing Director of RSA Switzerland.

October 9, 2012

WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced plans to move the company's global headquarters within the state from Whitehouse Station, N.J. to its existing...

October 9, 2012

HAYWARD, Calif.--(BUSINESS WIRE)--Impax Laboratories, Inc. (NASDAQ: IPXL) announced today that its third quarter 2012 financial results will be released before the market opens on Tuesday, October 30, 2012 and will be available on Impax’s Web...